Alere has issued a voluntary correction to users of the Alere INRatio and INRatio 2 PT/INR Monitor system of certain medical conditions that should not be tested with the system (INRatio Monitor ...
Exemption of the system from virtually all CLIA rules gives more labs access to connectivity and data management capabilities for monitoring patients on warfarin therapy INDIANAPOLIS, Oct. 1, 2012 ...
Globally, how many patients are estimated to be taking Warfarin and what are the main reasons the drug is prescribed? There are roughly 10 million people worldwide taking Warfarin, accounting for more ...
Concerned over nine serious adverse events, three of which described bleeding associated with patient deaths, Alere Inc. of Waltham, MA issued a voluntary urgent recall of its PN 99008G2 INRatio2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback